11 - Lack of usefulness of systematic determination of azathioprine (AZA) metabolites during follow-up of inflammatory bowel disease (IBD) patients under thiopurinic therapy: final results of the Metaza Study
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.